Further Information
CXCL14, chemokine (C-X-C motif) ligand 14, BMAC, BRAK, KS1, Kec, MGC10687, MIP-2g, NJAC, SCYB14, bolekine, CXC chemokine in breast and kidney, small inducible cytokine B14, small inducible cytokine subfamily B (Cys-X-Cys), member 14 (BRAK)
Peptide ELISA: antibody detection limit dilution 1:32000.Western Blot:Not yet tested - our routinely used western blotting protocol does not allow detection of proteins as small as the ligand derived from its precursor or the precursor itself with calculated size of 13.1kDa according to NP_004878.2. Therefore we cannot recommend an optimal concentration and the antibody is an aspiring product. We would appreciate any feedback from people in the field - have any assay results been reported with other antibodies?
- Siezen CL, Bont L, Hodemaekers HM, Ermers MJ, Doornbos G, Van't Slot R, Wijmenga C, Houwelingen HC, Kimpen JL, Kimman TG, Hoebee B, Janssen R. Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes. The Pediatric infectious disease journal 2009 Apr 28 (4): 333-5.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Human, Mouse, Rat, Dog, Cow
The immunogen for this antibody is: KSVSRYRGQEHCLH
9547
chemokine (C-X-C motif) ligand 14
CXCL14
Homo sapiens
Liquid
NP_004878.2
20149565
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Cancer ,Immunology ,Innate Immunity
O95715